Lifeline Sci. S Share Discussion Threads

[kiwi10] 08/1/2010 16:40

CAN ANYONE TELL ME THE DIFFERENCE BETWEEN LSI AND LSIC....THANKS....REGARDS

[daicaprice] 08/1/2010 11:19

Well that worked a treat, managed to knock you all back by 3p! And to make it worse due to squaters in one of my properties and being out all night in -12 I ended up paying 115p! Doh!!

[daicaprice] 07/1/2010 20:37

dipping me toe in gents, an if my toe works like it did today for RLH we could be in for a laugh. Good luck all.

[investinggarden] 04/1/2010 12:25

Trading cheer from Lifeline Scientific

[pejaten] 04/1/2010 08:24

A nice positive trading statement :)

[mikeja] 22/12/2009 09:52

The US government grants announced in October indicated huge potential for LSI
the bulk of the grant is for research into liver transplant transportation this is potentially a huge market.
Average PE projections for this yea and next indicate earnings of 6.5 P. and 10p.

[everlastian] 16/12/2009 09:21

Pejaten,

Thank you for the information!

I hold the LSI.

Kind regards

[pejaten] 14/12/2009 20:35

On another point, interesting to see director purchasing shares in Oct/Nov, with announcement today. these were purchased at up to 78p. Risen someway since, but still looks positive

[pejaten] 14/12/2009 20:33

LSI is the underlying share. If you have these (as I do) they have to be held in physical form.

LSIC are crestable shares. If you have these you can trade them through crest. This makes it easier to settle, etc.

If you have LSI shares you can apply to have converted into LSIC shares. Trouble is that the market is even less liquid than for LSI shares.

[everlastian] 14/12/2009 17:37

Can someone explain what is the other share LSIC about?

[pejaten] 14/12/2009 11:29

Normally stock exchange would require company to issue a statement explaining a significant share price move. I would have thought they would ask for one here as well. I guess if it comes it will be after USA wake up

[everlastian] 14/12/2009 11:14

Fordian,

Dont be pessimistic.

This share is a success case.

[balcony] 14/12/2009 10:00

Another huge rise this morning

[fordian] 11/12/2009 13:02

what the heck's goin on with this share?? Nothing goes straight up! Watch for the rebound...

[mikeja] 10/12/2009 16:48

will cling to mine

[everlastian] 10/12/2009 14:53

Another agreement to be announced by the end of this week or next a friend tipped me

[mikeja] 10/12/2009 13:46

Something going on here,up 11p on no volume whatsoever!

[fordian] 09/12/2009 12:03

Aha - I was wondering why this spiked - that explains it

Seems to be bags of potential for this company - with the disposals providing regular income following the sale of the original lifeport...

[robson1974] 07/12/2009 14:13

RHPS having an impact today

[masurenguy] 05/12/2009 18:49

Interim Results for the Six Months Ended 30 June 2009
23 September 2009

Financial Highlights
· Revenues increase by 123% to $7.8m (2008: $3.5m)
· $6.7m of revenue stemmed from sales of single use consumable items (86%)
· Gross Profit increased by 168% to $4.3m (2008: $1.6m)
· Maiden Interim Operating Profit of $73,080 (2008: loss of $3.1m)
· Cash of $1.2m at period end

Approximately 326 LifePorts are now in use globally; 11 were sold in the first half of 2009. The first sales of LifePort in Italy were achieved with transplant centres in the Bologna region. Italy is one of Europe's largest markets for renal transplant procedures. Trading from the end of the interim period has continued to be strong and management is confident of a good performance in the second half of the year.

The global shortage in human donors continues to increase with the forecast US and EU official waiting lists for a donor kidney to reach over 100,000 patients by 2014 and demand also increasing from the major emerging markets. Each year tens of thousands of people die waiting for a transplant and many more on the waiting list endure inconvenient and expensive dialysis. The continued dissemination of scientific evidence of LifePort's ability to improve renal transplant outcomes and help lower the overall costs of transplant should encourage further LifePort adoption and usage. The commercial roll out of the LifePort is still at an early stage and we believe that sales growth can be maintained as transplant centres throughout the world start to adopt LifePort as part of their standard practices for kidney preservation.

Grant funding from the US National Institutes of Health and other agencies continues to drive research and development of the LifePort platform for extra-renal organs. Lifeline continues to perform in line with our expectations and we are confident of delivering another strong performance in the second half of 2009.

Consolidated Statements of Operations
Six months ended 30-Jun-09. Six months ended 30-Jun-08
Fee and sales revenue $ 7,111,033 $ 2,895,152
Contract revenue - 48,000
Grant revenue 640,863 537,768
Total Revenue 7,751,896 3,480,920

Cost of Revenue 3,486,046 1,837,544
Gross Profit 4,265,850 1,643,376
Operating Expense
Research and development 208,104 487,519
Selling, general and administrative 4,019,194 4,078,977
Loss on abandonment of patents - 201,200
(Gain) loss from disposal of property and equipment (34,530) 9,160
Total Operating Expense 4,192,768 4,776,856
Income (Loss) from Operations 73,082 (3,133,480)
Other Expense (Income)
Interest expense 37,332 61,217
Interest income (9,272) (33,834)
Total Other Expense, Net 28,060 27,383
Net Income (Loss) $ 45,022 $ (3,160,863)

[masurenguy] 05/12/2009 18:47

12 August 2009
LifePort Recognised as Key Medical Device

Lifeline Scientific, the medical technology company focused on commercialising its LifePort® Kidney Transporter, an advanced organ preservation and transport system, designed to address the global challenge of human donor organ shortages, announces that Medical Device & Diagnostic Industry ("MDDI") magazine has recognised the LifePort® Kidney Transporter as one of the top medical devices of the past 30 years. In celebration of their 30th anniversary MDDI magazine honored the top 30 medical devices from the past 30 years. The LifePort® Kidney Transporter made the list and stands among many groundbreaking medical inventions including the Blood and Cell Separator and the Angioplasty Balloon Catheter. MDDI praised the LifePort by saying: "The product uses mobile machine perfusion to improve transplant outcomes, allowing the use of more organs and lowering the number of organs discarded."

David Kravitz, Chief Executive of Lifeline, said: "It is a tremendous achievement for the LifePort to be recognised alongside those devices that have helped
shape medicinal practice over the past 30 years. LifePort is off to a strong start and we are grateful for the opportunity to help advance transplant medicine worldwide."

[masurenguy] 05/12/2009 18:38

There are now approximately 326 LifePorts in use around the world with over 17,000 kidneys having been preserved on LifePort for clinical transplant.
65 LifePorts were sold in 2008: 11 in Canada, 36 in the US, 18 in RoW.

LifePorts are now used in 90 transplant centres, across 16 countries, with 14 new transplant program clients added during 2008. Successful pilot launch of the new SPS.1 organ flush solution during the 4th Qtr helped to grow revenue and further establish the Company presence as a one stop resource for organ preservation requirements.